Furthermore, research into natural P-gp inhibitors has highlighted their potential for effective drug delivery with reduced toxicity [108], while dual inhibitors targeting both P-gp and BCRP have shown promise in improving oral bioavailability and tumor reduction in animal models [109]. Here, PGP is linked to neoplasm.